Methyltestosterone
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Methyltestosterone contains NLT 97.0% and NMT 103.0% of methyltestosterone (C₂₀H₃₀O₂), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: ▲197A or▲ (USP 1-May-2024) 197K
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Change to read:
Procedure
▲[Note—Protect solutions containing methyltestosterone from light.]▲ (USP 1-May-2024)
Mobile phase: Acetonitrile and water (55:45)
Standard stock solution: 0.25 mg/mL of USP Methyltestosterone RS in methanol
Standard solution: 0.02 mg/mL of USP Methyltestosterone RS from the Standard stock solution in Mobile phase
System suitability stock solution: 0.25 mg/mL of USP Testosterone RS in methanol
System suitability solution: ▲0.02 mg/mL each of USP Methyltestosterone RS and USP Testosterone RS in Mobile phase prepared as follows.▲ (USP 1-May-2024)
Dilute 4 mL of the System suitability stock solution with the Standard solution to 50 mL.
Sample stock solution: 0.50 mg/mL of Methyltestosterone in methanol
Sample solution: 0.02 mg/mL of Methyltestosterone from the Sample stock solution in Mobile phase
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 241 nm
Column: 4-mm × 25-cm; ▲5-µm▲ (USP 1-May-2024) packing L1
Flow rate: 1 mL/min
Injection volume: 50 µL
System suitability
Samples: Standard solution and System suitability solution
[Note—The relative retention times for testosterone and methyltestosterone are about 0.8 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 2.0 between testosterone and methyltestosterone, System suitability solution
▲ (USP 1-May-2024)
Tailing factor: NMT 2.7, Standard solution
Relative standard deviation: NMT ▲1.10%,▲ (USP 1-May-2024) Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of methyltestosterone (C₂₀H₃₀O₂) in the portion of Methyltestosterone taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × 100
rᵤ = peak response of methyltestosterone from the Sample solution
rₛ = peak response of methyltestosterone from the Standard solution
Cₛ = concentration of USP Methyltestosterone RS in the Standard solution (mg/mL)
Cᵤ = concentration of Methyltestosterone in the Sample solution (mg/mL)
Acceptance criteria: 97.0%–103.0% on the dried basis
4 IMPURITIES
Change to read:
Organic Impurities
▲[Note—Protect solutions containing methyltestosterone from light.]▲ (USP 1-May-2024)
Solution A: Methanol and water (55:45)
Solution B: Methanol
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 100 | 0 |
| 20 | 60 | 40 |
| 40 | 0 | 100 |
| 45 | 0 | 100 |
| 60 | 100 | 0 |
System suitability solution: ▲0.5 mg/mL of USP Methyltestosterone RS and 0.005 mg/mL of USP Testosterone RS in methanol
Sensitivity solution: 0.25 µg/mL of USP Methyltestosterone RS in methanol
Standard solution: 0.5 µg/mL of USP Methyltestosterone RS in methanol▲ (USP 1-May-2024)
Sample solution: 0.5 mg/mL of Methyltestosterone in methanol
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
▲Temperatures
Autosampler: 5°
Column: 30°▲ (USP 1-May-2024)
Flow rate: 1 mL/min
Injection volume: ▲10 µL▲ (USP 1-May-2024)
System suitability
Samples: ▲ (USP 1-May-2024) System suitability solution, ▲Sensitivity solution, and Standard solution
[Note—The relative retention times in Table 2 are provided as information that could aid in peak assignment.]
Table 2
| Name | Relative Retention Time |
|---|---|
| Androstenedioneᵃ | 0.76 |
| Testosterone | 0.88 |
| Methyltestosterone | 1.0 |
| Epimethyltestosteroneᵇ | 1.31 |
ᵃ Androst-4-en-3,17-dione.
ᵇ 17α-Hydroxy-17-methylandrost-4-en-3-one.
▲ (USP 1-May-2024)
Suitability requirements
▲Resolution: NLT 1.5 between testosterone and methyltestosterone, System suitability solution▲ (USP 1-May-2024)
Relative standard deviation: NMT ▲5.0%, Standard solution▲ (USP 1-May-2024)
Signal-to-noise ratio: NLT ▲10, Sensitivity solution▲ (USP 1-May-2024)
Analysis
Samples: ▲Standard solution and▲ (USP 1-May-2024) Sample solution
▲Calculate the percentage of any specified and unspecified impurity in the portion of Methyltestosterone taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × (1 / F) × 100
rᵤ = peak response of any specified or unspecified impurity from the Sample solution
rₛ = peak response of Methyltestosterone from the Standard solution
Cₛ = concentration of USP Methyltestosterone RS in the Standard solution (mg/mL)
Cᵤ = concentration of Methyltestosterone in the Sample solution (mg/mL)
F = relative response factor (see Table 3)
▲ (USP 1-May-2024)
Acceptance criteria: ▲See Table 3. The reporting threshold is 0.05%.
Table 3
| Name | Relative Response Factor | Acceptance Criteria, NMT (%) |
|---|---|---|
| Androstenedione | 0.98 | 0.15 |
| Testosterone | 1.04 | 0.10 |
| Epimethyltestosterone | 0.97 | 0.5 |
| Any unspecified impurity | 1.0 | 0.10 |
| Total impurities | — | 1.0 |
▲ (USP 1-May-2024)
5 SPECIFIC TESTS
Optical Rotation 〈781S〉, Procedures, Specific Rotation
Sample solution: 10 mg/mL of Methyltestosterone in alcohol
Acceptance criteria: +79° to +85°
Loss on Drying 〈731〉
Analysis: Dry at 105° for 4 h.
Acceptance criteria: NMT 2.0%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed, light-resistant containers.
USP Reference Standards 〈11〉
USP Methyltestosterone RS
USP Testosterone RS

